[Clinical experience with the amphocholeretic drug Odibil in primary and secondary organic as well as functional cholecysto- and cholangiohepathopathies].
D000328:Adult; D000368:Aged; D000470:Alkaloids / Q000627:therapeutic use; D002756:Cholagogues and Choleretics / Q000627:therapeutic use*; D002761:Cholangitis / Q000188:drug therapy*; D002764:Cholecystitis / Q000188:drug therapy*; D002986:Clinical Trials as Topic; D005260:Female; D006505:Hepatitis / Q000188:drug therapy*; D006801:Humans; D008297:Male; D008875:Middle Aged; D010936:Plant Extracts
D000470:Alkaloids; D002756:Cholagogues and Choleretics; D010936:Plant Extracts
Klinische Erfahrungen mit dem Amhocholeretikum Oddibil bei primär und sekundär organischen sowie fundtionellen Chylezystound Cholangiohepatopathien